In prostate cancer cells, it was also recently reported that the negative impact of KAI1 on epithelial-to-mesenchymal transition was due to its interactions with the integrins α3ß1 and α5ß1, its interference with integrin activation, and, consequently, its hinderance of integrin signaling via FAK. This evidence concerns the gene CD82 and prostate carcinoma.